Subchronic microcystin-LR exposure increased hepatic apoptosis and induced compensatory mechanisms in mice

J Biochem Mol Toxicol. 2012 Mar-Apr;26(4):131-8. doi: 10.1002/jbt.20419. Epub 2012 Mar 23.

Abstract

Acute lethal cytotoxicity of microcystin-LR (MC-LR), a toxin produced by fresh-water cyanobacteria, has been attributed to protein phosphatases type 1 and type 2A (PP1/PP2A) inhibition and reactive oxygen species (ROS) generation. However, the effects and molecular mechanisms of prolonged, sublethal MC-LR exposure are less known. We studied mice intraperitonealy injected with saline or 25 μg MC-LR/kg for 28 days (every 2 days). MC-LR induced apoptosis in liver and not in kidneys or heart of treated animals. Liver also showed decreased α-tubulin levels (45.56% ± 7.65% of controls) and activation of p38-MAPK and CaMKII pathways (137.93% ± 11.64% and 419.35% ± 67.83% of the control group, respectively). PP1/PP2A activity decreased from 1.82 ± 0.23 (controls) to 0.91 ± 0.98 mU/mg (MC-LR-treated mice); however, no difference in total Ser/Thr phosphatase activity was found between both the groups. The results demonstrated that apoptosis and cytoskeleton disruption contributed to the hepatic cytotoxic effects of subchronic MC-LR administration. These effects occurred in association with sustained activation of signaling cascades and development of compensatory mechanisms to maintain total Ser/Thr phosphatase activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / metabolism
  • Enzyme Activation / drug effects
  • Heart / drug effects*
  • Injections, Intraperitoneal
  • Kidney / drug effects*
  • Kidney / metabolism
  • Kidney / pathology
  • Liver / drug effects*
  • Liver / enzymology
  • Liver / metabolism
  • Liver / pathology
  • Male
  • Marine Toxins
  • Mice
  • Microcystins / administration & dosage
  • Microcystins / isolation & purification
  • Microcystins / toxicity*
  • Myocardium / metabolism
  • Myocardium / pathology
  • Protein Phosphatase 1 / antagonists & inhibitors
  • Protein Phosphatase 1 / metabolism
  • Protein Phosphatase 2 / antagonists & inhibitors
  • Protein Phosphatase 2 / metabolism
  • Reactive Oxygen Species / metabolism*
  • Signal Transduction / drug effects
  • Tubulin / metabolism
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Marine Toxins
  • Microcystins
  • Reactive Oxygen Species
  • Tubulin
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • p38 Mitogen-Activated Protein Kinases
  • Protein Phosphatase 1
  • Protein Phosphatase 2
  • cyanoginosin LR